RESEARCH SUPPORT, N.I.H., EXTRAMURAL
Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice.
No abstract text is available yet for this article.
Full text links
We have located links that may give you full text access.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app